Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Burden of chronic respiratory disease in Fujian province, 1990–2021

  • Yanrong Yin,

    Roles Writing – original draft, Writing – review & editing

    Affiliation Department of Chronic and Noncommunicable Disease Control and Prevention, Fujian Provincial Center for Disease Control and Prevention, Fuzhou, Fujian province, People’s Republic of China

  • Xiuquan Lin,

    Roles Software, Writing – original draft, Writing – review & editing

    Affiliation Department of Chronic and Noncommunicable Disease Control and Prevention, Fujian Provincial Center for Disease Control and Prevention, Fuzhou, Fujian province, People’s Republic of China

  • Wenling Zhong,

    Roles Methodology, Supervision, Writing – original draft, Writing – review & editing

    Affiliation Department of Chronic and Noncommunicable Disease Control and Prevention, Fujian Provincial Center for Disease Control and Prevention, Fuzhou, Fujian province, People’s Republic of China

  • Tiehui Chen,

    Roles Formal analysis, Supervision

    Affiliation Department of Chronic and Noncommunicable Disease Control and Prevention, Fujian Provincial Center for Disease Control and Prevention, Fuzhou, Fujian province, People’s Republic of China

  • Jingyu Chen

    Roles Writing – original draft, Writing – review & editing

    Chenjingyufjcdc@outlook.com

    Affiliation Department of Chronic and Noncommunicable Disease Control and Prevention, Fujian Provincial Center for Disease Control and Prevention, Fuzhou, Fujian province, People’s Republic of China

Abstract

Background

Chronic respiratory diseases (CRDs) are major public health problems with significant risk factors. This study aimed to analyze the disease burden and attributable risk factors of CRDs in Fujian, Southeast China, between 1990 and 2021 and provide a scientific basis for developing public health policies for Fujian government.

Methods

Data on incidence, prevalence, deaths, disability-adjusted life years (DALYs), and attributable risk factors for CRDs among Fujian residents were estimated as part of the Global Burden of Disease 2021 (GBD 2021) study at the provincial level. Joinpoint regression was used to assess the long-term temporal trends of the disease burden and identify the main risk factors of CRD between 1990 and 2021.

Results

In 1990, there were 0.22 million (95% CI: 0.20–0.28) new CRD cases and 1.56 million (95% CI: 1.38–1.78) patients with CRDs, increasing up to 0.24 million (95% CI: 0.21–0.28) new cases and 2.00 million (95% CI: 1.80–2.24) patients with CRDs in 2021. However, the age-standardized incidence rate, age-standardized prevalence rate, age-standardized mortality rate, and age-standardized DALY rate decreased by 29.63%, 29.26%, 75.92%, and 73.62% in Fujian (all P < 0.01) in these 32 years. The DALYs for CRDs were higher in males, patients older than 50 years, and patients with COPD. Smoking, ambient particulate matter pollution, and occupational exposure were the top three attributable risk factors of DALYs for CRDs in Fujian in 2021. Moreover, the proportion attributed to household air pollution from solid fuels significantly decreased.

Conclusion

The total CRD burden in Fujian province decreased, but the number of new cases and patients continuously increased. The ranking of risk factors of CRDs has changed between 1990 and 2021. Older men, smokers, and people with occupational exposure were the key groups that relieved the CRD burden. Efforts should focus on quitting smoking and reducing air pollution.

Introduction

Chronic respiratory diseases (CRDs) are a group of long-term diseases characterized by structural or functional abnormalities of the lungs and airways [1]. Common CRDs include chronic obstructive pulmonary disease (COPD), asthma, interstitial lung disease and pulmonary sarcoidosis (ILDPS), pneumoconiosis, and other CRDs [1,2]. CRDs are incurable, and patients often experience respiratory symptoms, such as dyspnea, cough, sputum production, and acute exacerbation [1]. In 2021, the global prevalence of CRDs was estimated at 468 million cases, with approximately 4.41 million deaths, making CRDs the fourth leading cause of death worldwide [2,3]. In China, CRDs ranked as the third leading cause of death, with an estimated 1.33 million deaths annually [2,3]. The main risk factors for CRDs were smoking, air pollution, and occupational exposure [1,2]. As one of the four major chronic diseases globally, CRDs impose a significant burden on public health due to their high mortality and disability rates, which severely compromise the quality of life and place a substantial economic and social strain on patients and their families [4].

The “Healthy China Initiative (2019–2030)” and the “Medium and Long-Term Plan for Chronic Diseases in Fujian Province (2017–2025)” have clearly outlined specific targets, including “reducing the premature mortality rate due to major chronic diseases and effectively controlling the disease burden of chronic diseases” [2,5,6]. Recently, the “Healthy China Initiative-Implementation Plan for the Prevention and Control of CRDs (2024–2030)” has also outlined specific goals for public health strategies aimed at preventing and controlling CRDs [2,7].

To date, reports on the burden of CRDs in Fujian province are lacking. This study used GBD 2021 data to analyze the changes in the burden and attributable risk factors of CRDs among Fujian residents between 1990 and 2021.

Materials and methods

Source of materials

The GBD 2021 database can be downloaded and obtained through the Global Health Data Exchange website (https://vizhub.healthdata.org/gbd-results) [2]. It provides the most comprehensive disease burden indicators, including incidence, prevalence, mortality, disability-adjusted life years (DALYs), and attributable risk factors. The database encompasses 371 diseases or injuries in 204 countries and regions, spanning from 1990 to 2021, and employs a unified and comparable methodology. It also estimates the attributable disease burden of 88 risk factors, stratified by age, sex, and year [2]. The data of GBD 2021 of Fujian province was as a part of China GBD 2021. GBD information is anonymous and publicly available for download, does not collect personal data, and does not require ethical approval for use.

Analytical indicators

The incidence rate, prevalence rate, mortality rate, and DALYs for CRDs worldwide, in China, and in Fujian province were used as health indicators for measuring the burden of CRDs. DALYs refer to all the healthy life years lost from the onset of the disease to death. It includes two parts: years of life lost (YLLs) due to premature death and years of life lost due to disability (YLDs). The DALY estimates from the GBD 2021 analysis, which were used for this study, incorporate the standard GBD comorbidity adjustment to prevent the double-counting of disability.

GBD 2021 adopted the concept of population-attribution fraction (PAF) of DALYs, which is defined as quantifying the magnitude of the pathogenic or lethal effect of a certain risk factor on the population. We utilized the proportions of eight attributable risk factors to that contributed to DALYs and deaths from CRDs, namely smoking, occupational exposure, ambient particulate matter (PM) pollution, household air pollution from solid fuels, secondhand smoke, ambient ozone pollution, low temperature, and high temperature,which were processed by GBD 2021 team [8].

Statistical analysis

We conducted a descriptive data analysis of the disease burden and various indicators among residents of Fujian province between 1990 and 2021 using Excel 2017 software. Age-standardized rates (ASRs; rates per 100,000) represented the disease burden, including the age-standardized incidence rate (ASIR), age-standardized prevalence rate (ASPR), age-standardized mortality rate (ASMR), age-standardized DALYs rate (ASDR), age-standardized YLLs rate (ASYLLR), and age-standardized YLDs rate (ASYLDR). The ASRs were calculated based on the global standard population age structure in the GBD 2021 report.

The Joinpoint 5.1.0 software developed by the National Cancer Institute of the United States was used, and a log-linear model was employed to calculate the annual percent change (APC) and the average annual percent change (AAPC). An annual trend analysis was conducted on the AAPC and its 95% confidence interval (95% CI). The changing ASIR, ASPR, ASMR, and ASDR trends of CRDs in the Fujian province were statistically analyzed. A two-sided significance level (α) of 0.05 was adopted.

Results

Changes in the CRD disease burden in Fujian between 1990 and 2021

In 2021, 241,441 (95% CI: 210,978–284,998) new cases of CRDs were reported among Fujian residents, which was 5.28% higher than in 1990. The total number of patients with CRDs in 2021 in Fujian was 2.00 million (95% CI: 1.80–2.24), an increase of 28.06% compared to that in 1990. There were 22,532 (95% CI: 17,232–28,787) CRD-related deaths in 2021 and 27,564 (95% CI: 22,192–32,928) deaths in 1990, indicating a decrease of 18.26% over the past 32 years.

The DALYs for CRDs in Fujian was 0.47-million-person years (95% CI: 0.38–0.57), decreasing by 26.03% compared with that in 1990. The YLLs for CRDs in Fujian in 2021 were 0.34 million (95% CI: 0.26–0.44) person-years, with a decrease of 37.61%. The YLDs during the same period were 0.13 million (95% CI: 0.10–0.16) person-years, increasing by 46.87% compared to that in 1990.

In 2021, the ASIR for CRDs among Fujian residents was 601.15 per 100,000 (95% CI: 511.05–737.42), decreasing by 29.63% compared to that in 1990. The AAPC of ASIR between 1990 and 2021 was −1.14% (95% CI: −1.25 to −1.04), and it was statistically significant. The ASPR for CRDs in 2021 was 4,391.81 per 100,000 (95% CI: 3875.90–5014.08), decreasing by 29.26% compared to that in 1990. The AAPC of ASPR between 1990 and 2021 was −1.12% (95% CI: −1.19 to −1.05). The ASMR for CRDs in Fujian in 2021 was 50.53 per 100,000 (95% CI: 38.36–64.36), decreasing by 75.93% over 32 years. The AAPC of ASMR was −4.51% (95% CI: −5.04 to −3.98) during the same period.

The ASDR for CRDs in Fujian in 2021 was 980.97 per 100,000 (95% CI: 804.50–1195.49), decreasing by 73.62%. The AAPC of ASDR was −4.23% (95% CI: −4.52 to –3.93). Precisely, the ASYLLR reduced from 3,350.00 per 100,000 in 1990 to 712.56 per 100,000 in 2021, a decrease of 78.73%, with an AAPC of −4.89 (95% CI: −5.33 to −4.45). The ASYLDR decreased from 368.76 per 100,000 in 1990 to 268.41 per 100,000 in 2021, a decrease of 27.21%, with an AAPC of −1.02 (95% CI: −1.05 to −0.99, Table 1).

thumbnail
Table 1. The change of disease burden of CRD by sex in Fujian, 1990-2021.

https://doi.org/10.1371/journal.pone.0335352.t001

Changes in CRD burden in different sexes

From 1990 to 2021, the number of new cases and the total number of patients with CRDs among males and females in Fujian showed an upward trend. Approximately 1.03 million (95% CI: 0.93–1.16) male patients had CRDs in 2021, representing a 26.47% increase from the number in 1990. More males had CRDs than females, with 0.96 million (95% CI: 0.86–1.08) patients in 2021, representing a 29.81% increase from the 1990 prevalence. Meanwhile, the number of deaths, DALYs, and YLLs among both males and females decreased. The number of YLDs by women increased by 53.47% between 1990 and 2021, which was higher than the increase among men (39.28%).

Compared to the 1990 data, the ASIR, ASPR, ASMR, and ASDR in 2021 exhibited decreasing trends in both sexes. The ASIR was 668.60/100,000 in males and 531.55/100,000 in females in 2021. Compared with 1990, the ASIR decreased by 28.27% in males and 31.96% in females. The ASPR among men was 4597.77/100,000 and 4138.45/100,000 among women. Over the past 32 years, the ASPR of men decreased by 28.48%, and that of women decreased by 30.55%. In 2021, the ASMR was 82.09/100,000 in males and 30.74/100,000 in females. The ASMR decreased by 72.40% in males and 81.26% in females. The ASDR was 1360.18/100,000 in males and 708.56/100,000 in females in 2021. Compared with 1990, the ASDR decreased by 72.61% in males and 75.62% in females. Precisely, the age-standardized YLLs and YLDs rates showed decreasing trends (Table 1).

Changes in CRD burden in different age groups

The entire population was divided into five age groups. The numbers of new cases, patients, and deaths from CRDs among 0–5-year-olds, 5–14-year-olds, and 15–49-year-olds all showed decreasing trends. However, the number of new cases and patients with CRDs among 50–69-year-olds and those above 70 years old increased. Particularly among those above 70 years old, the incidence of CRDs increased from 26,055 cases (95% CI: 22,752–29,172) in 1990–63,674 cases (95% CI: 54,757–72,269) in 2021, and the prevalence of CRDs increased from 248,065 cases (95% CI: 220,217–274,074) in 1990–639,718 cases (95% CI: 549,005–725,022) in 2021, increasing by more than 2.5 times. The number of deaths from CRDs only increased in the above 70-year-old age group, with an increase of 0.68%.

The DALYs of all five age groups showed downward trends. The decrease in the under-5 age group was 62.76%, and this decline was the most significant decline among the age groups. The YLLs in the under-5 age group decreased by 95.26%, the greatest decline in YLLs. By 2021, the YLDs in the 50–69-year-old age group had increased by 69.11%, and those in the above 70-year-old age group had increased by 160.75%. After age standardization, the ASR indicators of CRDs in each age group of Fujian residents all showed decreasing trends between 1990 and 2021. ASIR, ASPR, and ASDR showed the most significant decrease in the 50–69 years age group, decreasing by 48.66%, 42.98%, and 81.05%, respectively. The ASMR in children under 5 years old declined more significantly, with a reduction of 93.75% (Table 2).

thumbnail
Table 2. The change of disease burden of CRD by age groups in Fujian, 1990-2021.

https://doi.org/10.1371/journal.pone.0335352.t002

Changes in the CRD burden attributable to five diseases

According to GBD 2021, CRDs are classified into five major categories, including COPD, asthma, pneumoconiosis, ILDPS, and other CRDs. From 1990 to 2021, the incidence and prevalence of CRDs increased. The incidence and prevalence of COPD, pneumoconiosis, and ILDPS increased by 88.77% and 105.72%, 48.82% and 106.97%, and 197.35% and 182.33%, respectively. In contrast, the incidence and prevalence of asthma decreased by 20.13% and 13.80%, respectively. The ASIR, ASPR, ASMR, and ASDR for CRDs, COPD, pneumoconiosis, and asthma all showed statistically significant decreasing trends. During these 32 years, the ASIR and ASPR of ILDPS increased by 18.80% and 8.67%, respectively (Table 3).

thumbnail
Table 3. The change of disease burden of CRD by categories in Fujian, 1990-2021.

https://doi.org/10.1371/journal.pone.0335352.t003

Changes in the CRD burden in different areas

The incidence and prevalence of CRDs showed upward trends worldwide, in China, and in Fujian. The global increase in the incidence and prevalence of CRDs was 10.84% and 22.83%, respectively; the increase in China was 5.36% and 34.29%, respectively; and the increase in Fujian was 5.24% and 28.03%, respectively. The number of CRD-related deaths increased by 47.49% and 3.10% globally and in China, respectively, while it declined by 16.56% in Fujian province. The DALYs and YLLs increased worldwide. In contrast, DALYs and YLLs showed a downward trend in China and Fujian. Compared to 1990, the global YLDs increased by 41.38% in 2021, with YLDs rising by 56.27% and 47.15% in China and Fujian, respectively.

All CRD ASRs showed decreasing trends. The global AAPC of ASIR was −0.88 (95% CI: −0.94 to −0.82), with the AAPC of ASIR being −1.02 (95% CI: −1.15 to −0.89) and −1.14 (95% CI: −1.25 to −1.04) in China and Fujian, respectively. The rate of decline of the incidence of CRDs was faster in Fujian than globally and in China. The ASPR, ASMR, and ASDR for CRDs also demonstrated the same downward trends. In addition, the decline in the AAPC of ASPR, ASMR, and ASDR for CRDs in Fujian was faster than those in the world and China during the same period (Table 4).

thumbnail
Table 4. The change of disease burden of CRD in different region, 1990-2021.

https://doi.org/10.1371/journal.pone.0335352.t004

Attribution of major risk factors of CRDs

Among the risk factors identified by GBD 2021, smoking was the most important contributor to DALYs for CRDs, accounting for 352.05 (95% CI: 242.12–473.24) per 100,000 people. The AAPC of ASDR of smoking between 1990 and 2021 was −4.30% (95% CI: −4.88 to −3.71), accounting for 35.82% (95% CI: 27.49–43.01) of the attributable risk for CRD DALYs in Fujian province. Ambient PM pollution ranked as the second most important risk factor, accounting for 17.51% (95% CI: 13.88–20.89) of CRD DALYs, and its AAPC of ASDR of ambient PM pollution was −2.44% (95% CI: −2.78 to −2.11). Occupational exposure ranked as the third most important factor, accounting for 14.57% (95% CI: 11.74–17.26) of CRD DALYs, and its AAPC of ASDR was −4.47% (95% CI: −4.88 to −4.06).

During these 32 years, the contribution of household air pollution from solid fuels to CRD DALYs decreased the most. In 1990, household solid fuels contributed 1994.40 (95% CI: 1474.58–2502.64) per 100,000 people CRD DALYs, accounting for 53.60% (95% CI: 43.67–61.73) of CRD DALYs in 1990. However, in 2021, it accounted for only 15.52 (95% CI: 0.14–124.47) per 100,000 people and only 1.59% of CRD DALYs (95% CI: 0.01–13.05). The AAPC of ASDR between 1990 and 2021 was −14.68% (95% CI: −14.96 to −14.40). The proportion of DALYs attributed to various factors, including smoking, occupational exposure, secondhand smoke, low temperatures, ozone pollution, and high temperatures, remained stable over 32 years (Table 5 and Fig 1).

thumbnail
Table 5. The change of attribute risk factors of DALYs in CRD in Fujian, 1990-2021.

https://doi.org/10.1371/journal.pone.0335352.t005

thumbnail
Fig 1. The proportion of attributable risk factors of DALYs of CRD in Fujian, 1990-2021.

Legend: The bar charts showed the proportion of eight attributable risk factors of DALYs of CRD in Fujian. The height of each bar represented the percentage of DALYs for the risk factors, 95% CIs were not shown.

https://doi.org/10.1371/journal.pone.0335352.g001

Stratifying by sex, the ranking of risk factors among men was the same as that of the entire population. In contrast, the ranking of risk factors among women was different, with ambient PM pollution ranked first (17.36%, 95% CI: 13.70–20.88), secondhand smoke ranked second (11.56%,

Discussion

In this study, we utilized the data from the GBD 2021 to examine the burden of CRDs in Fujian province. The incidence and prevalence of CRDs in Fujian increased over the past 32 years. However, the ASIR, ASPR, ASMR, and ASDR for CRDs all showed significant downward trends. Similar to the changing trends of CRDs studied at home and abroad, the burden of CRDs in Shanghai [9] and Jiangsu province [10] also showed downward trends. Previous studies have primarily reported the burden of CRDs at regional and national levels [11], while few studies have reported provincially representative data. Moreover, all indicators of disease burden were in Fujian than in the world and China.

As we know, after age-standardized by the global standard population, the age-structure differences have been removed. Thus, the age-standardized rate can be used to determine whether the true risk of CRD has changed. The main reasons for the significant decline in the overall CRD burden in recent years include improvement in economic and living standards, advancement in the management of medical conditions, and the availability of sufficient health resources, as well as increased health awareness among the public. The above have played positive roles in the prevention, diagnosis, and treatment of CRDs [10]. Due to the aging population, the incidence and prevalence of CRDs will continuously increase. Although the ASMR for CRDs is declining, CRDs are still ranked as the fourth leading cause of death in Fujian [12]. They remain predominant chronic diseases with a relatively heavy disease burden in Fujian province and require the attention of the government and society.

Effective CRD prevention and control measures should be applied to different age groups and sexes. Males bear a heavier disease burden than females. In 2021, the ASDR and ASYLLR for CRDs among male residents in Fujian province were 1360.18/100,000 and 1117.26/100,000, respectively, which were higher than the 708.56/100,000 and 420.59/100,000 among females. These findings are consistent with those of foreign and Chinese studies (9–11). The prevalence and burden of CRDs are greater among men, which may be related to the highly prevalent smoking behavior and occupational exposure to chemical dust and harmful gases among men [13]. Tobacco exposure in Fujian was higher among men. The current smoking rate among males is 56.2%, which is significantly higher than that of females (0.7%) [13]. Furthermore, the occupational dust and harmful gases exposure rate among males (43.4%) was also higher than that in females (29.4%) [13]. However, the ASYLDR among females was 287.97 per 100,000, which was higher than that among males (242.92 per 100,000). The finding indicates that women experienced more severe disability, which may be related to their longer life expectancy, higher frequency of exposure to cooking exhaust gas, and secondhand smoke [13]. Particular attention should be paid to the disease burden due to disability.

The burden of CRDs increases significantly with age. The CRD-related mortality rate among those under 49 years tended to be low and stable. Conversely, the mortality rate among people aged over 50 years increased significantly. This upward trend was remarkable and reached a peak in the group above 70 years old. This trend may be related to increasing age and the accumulation of multiple risk factors, resulting in organ decline and functional degradation [14]. CRDs have led to a decrease in the quality of life, disability, and increasing medical burden. Long-term CRDs can cause deterioration in lung function, loss of working ability, and the need for long-term care by family members, affecting work, creating other practical problems, and adding a heavy economic burden to families and society [4]. Residents in Fujian have relatively limited knowledge and awareness about CRDs [13]. High-risk groups and patients with CRDs have no obvious symptoms at the early stage of the disease. Even when they have symptoms, they do not receive sufficient attention and may not seek professional prevention and treatment early. Therefore, they often miss the best intervention period [15]. These results suggest that middle-aged and older people are the key population to be screened for CRDs, and they should be considered the high-risk population for CRDs.

COPD and asthma are the two main types of CRD, affecting the highest proportion of patients and making the greatest contribution to the burden of CRDs. Most patients with asthma are diagnosed at a young age. With the advancement in medicine, environment improvement and economic developed during these 32 years, the prevalence and ASRs of asthma are decreasing. This may be attributed to the improvement in asthma management through the introduction of inhaled corticosteroids (ICS) or a combination therapy of ICS with long-acting beta-agonists [16]. Moreover, the change in public policy and social economics may have played important roles in improving air quality, reducing tobacco usage, and creating awareness of early screening for asthma, which have influenced disease rates [17,18].

The number of patients with COPD and ILDPS significantly increases aging, and the number of patients with pneumoconiosis increased with industrialization level with a lack of necessary protective methods and healthy practices [13]. Most of the ASRs exhibited decreasing trends, with only the ASIR and ASPR for ILDPS showing an increase. This may be due to population aging, workplace exposure to dust, gases, heavy metals, and other pollutants, and the use of more advanced medical investigations, such as high-resolution CT, for lung disease evaluation and pulmonary examination [19], which might impact the progress of these chronic respiratory diseases. Moreover, these diseases are not curable, numberous treatment and medicine could only help to control clinical symptoms and improve life quality of CRD patients [11], leading to the rising trends in incidence and prevalence rates.

The early clinical symptoms and signs of CRDs are not obvious and can be easily ignored; therefore, patients and populations at high risk of CRDs may not identify these diseases early. Additionally, once these diseases persist and gradually deteriorate, they may become irreversible, imposing significant physical and economic burdens on patients, their families, and society [4]. Missed diagnosis and misdiagnosis of CRDs persists in China and Fujian province, which might lead to an underestimation of the actual number of cases and deaths due to CRDs [20]. Pulmonary function tests should be popularized among older persons as early as possible. Corresponding measures, such as health education of high-risk groups, timely diagnosis and treatment of patients, encouraging patients to use inhalation drugs regularly, undergoing respiratory function recovery training, and improving nutritional support for patients, should be taken when high-risk groups are identified to reduce the burden of CRDs [10].

The attributable risk factors were ranked as follows: smoking, ambient PM pollution, and occupational exposure. These are the top three risk factors for CRDs in Fujian. The GBD attributed to ambient PM pollution is the highest, accounting for approximately 8.0% (95% CI: 6.7–9.4) of the total DALYs. Smoking accounts for 5.7% (95% CI: 4.7–6.8) of DALYs globally [21]. This global ranking differs slightly from the ranking of risk factors of CRDs in Fujian province.

More than 1.14 billion people are current smokers, and the smoking prevalence exceeds 20% globally [22]. The smoking rate among people aged 40 and above was 44.8% (males 80.0%, females 2.5%) in Fujian province in 2015, the smoking rate was 42.4% (males 78.5%, females 0.9%) in Fujian province in 2020 [13]. The smoking rate decreased, however, the smoking behaviour remained highly popular [15]. Smoking has been repeatedly confirmed to be closely related to the occurrence and mortality due to various chronic diseases, such as ischemic heart diseases, lung cancer, and respiratory diseases [22]. Tobacco smoke not only influences the pathogenesis of COPD, pneumoconiosis, and ILDPS but is also the main risk factor that impacts the progress of asthma [16]. The exposure of adults to secondhand smoke in Fujian is also not encouraging. Surveys indicate that 77.2% of residents reported they were exposed to secondhand smoke daily [23]. It indicated that tobacco use and smoke exposure were still widespread in the daily lives of Fujian residents [23]. To reduce the demand for tobacco products, coercive and restrictive measures were adopted, including raising tobacco tax rates [22], clarifying health warning requirements through legislation, creating more smoke-free working environments and public places, and strictly prohibiting tobacco advertising.

With rapid economic development and industrialization, environmental PM pollution and occupational exposure have become public problems. Waste gas from the combustion of various fuels in industries, exhaust gas from vehicles, and chemical dust and gases in working places contain toxic dust and other harmful substances. Air pollution, primarily consisting of PM10 and PM2.5, stimulates the human respiratory tract and lungs, increasing the risk of CRDs. Moreover, long-term and repeated exposure to these pollutants increases the risk of adverse health outcomes [24]. These air pollutants led to increasing trends in the number of new cases, prevalence, deaths, and DALYs due to pneumoconiosis and ILDPS in the GBD 2021. Occupational exposure rate among middle-aged and elderly population was 50.0% in Fujian residents in 2015, 56.1% in males and 39.7% in females. This rate decreased to 36.8% in Fujian population in 2020, 43.4% in males and 29.4% in females, with decreasing trends in both gender [13]. Environmental and health departments need to strengthen efforts to improve air quality and working environment. It is also necessary to strengthen early warning and forecasting of extreme weather and environmental pollutants to improve the living environment of Fujian residents.

The most remarkable decline among all the risk factors was in household air pollution from solid fuels. Many farmers easily collected wood and crops as free fuels for cooking and heating from the natural environment in 1990. With improvements in the economy and health awareness, an increasing number of people have accepted the concepts of environmental protection and a healthy lifestyle. Consequently, the consumption of biomass fuels in rural areas in China has decreased by more than 50%, and individuals have made the right choice of transitioning from using polluted energy to using environmentally friendly energy during the last three decades [25,26]. With the effectiveness of environmental protection policies and economic development, Fujian residents shifed biomass fuel consumption into clean energy usage, reducing the health and economic impacts of pollution. The proportion of household polluting fuel for cooking and heating was 37.2% and 3.5% in 2015, the data declined to 25.2% and 0.8% in 2020 in Fujian province in a decling trend [13].

Recently, the Chinese government realized the serious impact of CRD and has focused on several regular screening and intervention projects for high-risk populations and patients with CRDs in grassroots medical and health institutions [7]. Comprehensive and multi-dimensional health education on disease prevention and behavioral intervention was also improved for the public. The government has taken multiple measures to enhance public awareness, including regular follow-up physical examinations, the introduction of early symptoms and signs of CRDs, recommendations for pulmonary function tests and healthy lifestyles for high-risk populations, the use of new media publicity channels, and increasing the frequency and duration of information promotion.

This study was the first to evaluate the burden of CRDs in Fujian between 1990 and 2021 at the provincial level, and its results reflected the impact of CRDs among Fujian residents. The results of this study provide scientific support for informed prevention policy and effective government decision-making. Our study has several limitations. First, we only estimated the burden of CRDs at the provincial level. We did not divide the province into smaller sections at the city or county level. More detailed studies on the burden of CRDs by district and city or by urban and rural areas should be performed in the future. Second, because the GBD 2021 data are derived from multiple health information systems in China, the accuracy and reliability of the data rely on the coverage of monitoring sites and the quality of the original data in various programs in China. Third, the GBD method employed statistical models to evaluate and predict data under ideal conditions, which introduces some uncertainty and bias; therefore, the results should be interpreted carefully in the real world. In future studies, more efforts should be made to obtain more accurate and accessible epidemiological data for GBD research.

Conclusion

Our study revealed that the overall CRD burden in Fujian province decreased at the provincial and regional level between 1990 and 2021. The ASIR, ASPR, ASMR, and ASDR for CRDs among Fujian residents generally showed downward trends. However, the incidence and prevalence of CRDs increased. Therefore, CRDs remain an important public health problem in Fujian. Health education programs to prevent and control CRDs should target middle-aged and older men. Controlling smoking, protecting the environment from air pollution, and preventing occupational exposure should be prioritized in future public health policies in Fujian.

Acknowledgments

The authors would like to thank all the staff members in Center for Disease Control (CDC) and health institution which joined in the GBD 2021 data supply in Fujian province. We also thank Chronic Disease Center of China CDC for technical support in this research.

References

  1. 1. World Health Organization. Chronic Respiratory Diseases. (2025). Available from: https://www.who.int/health-topics/chronic-respiratory-diseases#tab=tab_1
  2. 2. Global Health Data Exchange. Global Burden of Disease (GBD) 2021. (2021). Available from: https://vizhub.healthdata.org/gbd-results/
  3. 3. Global Burden of Disease Network. Global Burden of Disease Study 2021 (GBD 2021) Results. Seattle (2022). Available from: https://vizhub.healthdata.org/gbd-results/
  4. 4. Chen S, Kuhn M, Prettner K, Yu F, Yang T, Bärnighausen T, et al. The global economic burden of chronic obstructive pulmonary disease for 204 countries and territories in 2020-50: a health-augmented macroeconomic modelling study. Lancet Glob Health. 2023;11(8):e1183–93. pmid:37474226
  5. 5. Central Government of China. Healthy China Initiative (2019-2030). (2019). Available from: https://www.gov.cn/gongbao/content/2016/content_5133024.htm
  6. 6. General Office of Fujian Government. Notice of the General Office of the Fujian Provincial People’s Government on the issuance of the Long-Term Plan for the Prevention and Treatment of Chronic Diseases in Fujian Province (2017-2025). (2017). Available from: https://wjw.fujian.gov.cn/xxgk/fgwj/gfxwj/201711/t20171106_2380647.htm
  7. 7. National Health Commission of China. Notice on the issuance of the Healthy China Action - Implementation Plan for the Prevention and Treatment of Chronic Respiratory Diseases (2024-2030). (2024). Available from: https://www.gov.cn/zhengce/zhengceku/202407/content_6964998.htm
  8. 8. GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2133–61. pmid:38642570
  9. 9. Dai Y, Chen Y, Li H, Zhao J, Han X, Yin J. Analysis and predictive analysis of the major chronic disease burden in Yangpu District, Shanghai from 2002 to 2021. Chin Prev Med (2024) 25:1185–90.
  10. 10. Xu WC, Zhou MM, Ding MK, Yu H, Zhu Z, Xu WG, et al. Disease burden and risk factors of chronic respiratory diseases in Jiangsu Province from 1990 to 2019. Zhonghua Yu Fang Yi Xue Za Zhi. 2023;57(8):1141–6. pmid:37574303
  11. 11. GBD Chronic Respiratory Disease Collaborators. Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med. 2020;8(6):585–96. pmid:32526187
  12. 12. Fujian Provincial Center for Disease Control and Prevention. Chronic Disease Surveillance and Analysis Report of Fujian Province (2023). 2024.
  13. 13. Fujian Provincial Center for Disease Control and Prevention. Fujian Province Chronic Obstructive Pulmonary Disease Surveillance and Analysis Report (2020). 2021.
  14. 14. Wu D, Zhao G, Cui C, Shi L, Li W, Zhang S. Analysis of the changing trends of premature mortality and potential shortened life expectancy of chronic respiratory diseases in Xi ‘an, 2014-2020. Chin J Health Stat. 2023;4:555–62.
  15. 15. Zhang Y, Chen J, Zhong W, Chen T, Hu X. Analysis on smoking status among residents aged 40 years and above in some areas of Fujian province, 2015. Prev Med Trib (2019) 25:435–7.
  16. 16. Wang Z, Li Y, Gao Y, Fu Y, Lin J, Lei X, et al. Global, regional, and national burden of asthma and its attributable risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. Respir Res. 2023;24(1):169. pmid:37353829
  17. 17. Okui T. Age-period-cohort analysis of asthma, allergic rhinitis, and atopic dermatitis prevalence in Japan. Environ Anal Health Toxicol. 2020;35(3):e2020012. pmid:32791576
  18. 18. Ryan-Ibarra S, Milet M, Lutzker L, Rodriguez D, Induni M, Kreutzer R. Age, period, and cohort effects in adult lifetime asthma prevalence in California: an application of hierarchical age-period-cohort analysis. Ann Epidemiol. 2016;26(2):87-92.e2. pmid:26762964
  19. 19. Chen S, Li Y. Global health inequalities in the burden of interstitial lung disease and pulmonary sarcoidosis from 1990 to 2021. BMC Public Health. 2024;24(1):2892. pmid:39511538
  20. 20. Chen RC, Zhao DX. Pay attention to the burden and patients’ characteristics of chronic obstructive pulmonary disease in China. Zhonghua Yi Xue Za Zhi. 2017;97(40):3121–3. pmid:29081158
  21. 21. Yang H, Ruan X, Li W, Xiong J, Zheng Y. Global, regional, and national burden of tuberculosis and attributable risk factors for 204 countries and territories, 1990-2021: a systematic analysis for the Global Burden of Diseases 2021 study. BMC Public Health. 2024;24(1):3111. pmid:39529028
  22. 22. GBD 2019 Tobacco Collaborators. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019. Lancet. 2021;397(10292):2337–60. pmid:34051883
  23. 23. Lin Z, Chen M, Chen J. Secondhand smoke exposure of urban and rural residents in Fujian Province in 2016-2017. The 11th Cross-Strait and Hong Kong and Macao Symposium on Tobacco Control and the 23rd National Symposium on Tobacco Control and Health; 2022. p. 18–9.
  24. 24. GBD 2019 Tobacco Collaborators. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019. Lancet. 2021;397(10292):2337–60. pmid:34051883
  25. 25. Tao S, Ru MY, Du W, Zhu X, Zhong QR, Li BG, et al. Quantifying the rural residential energy transition in China from 1992 to 2012 through a representative national survey. Nat Energy. 2018;3(7):567–73.
  26. 26. Wu M, Liu Y, Xu Z, Yan G, Ma M, Zhou S, et al. Spatio-temporal dynamics of China’s ecological civilization progress after implementing national conservation strategy. Journal of Cleaner Production. 2021;285:124886.